Tag archief: English Only

Apple Must Pay Fairly: PanOptis Campaign Shows Company’s Efforts to Devalue Essential IP

iProtectInnovation.com highlights Apple’s long-term scheme to undermine and underpay innovators and devalue essential patents Despite its innovative veneer, Apple has a long and ongoing record...

Survey Reveals: 88% of Western Europeans Would Like Better Information on Breast Cancer, Misconceptions and Lack of Awareness of the Disease Still Prevail

Survey with 7,750 participants highlights the urgent need for more and improved access to information about breast cancer and metastatic breast cancer across Europe Results...

Datopotamab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

Recommendation based on TROPION-Breast01 results showing Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced risk of disease progression or death by 37% versus chemotherapy Datopotamab deruxtecan...

GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end...

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

– Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY – – Agreement for CASGEVY in transfusion-dependent beta thalassemia...

IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)

First results from the phase IIIb RELAX clinical trial reinforce the high and sustained efficacy of single treatment of RelabotulinumtoxinA (RelfydessTM) for moderate to severe...

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

— JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than...

Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe

Second- and third-line treatment for adults with mycosis fungoides or Sézary syndrome reimbursed by Croatia’s National Health Insurance Fund (NHIF), effective as of 15th November...

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

CEO Christophe Weber to retire from Takeda in June 2026 after 12 years Julie Kim, president of the U.S. Business Unit, named to succeed Weber...

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Revenue Growth of +9.8% at Actual Exchange Rates (AER); +4.5% at Constant Exchange Rate (CER) Driven by Strong Momentum of Growth & Launch Products (+14.6%...

Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines

New research shows that loose or sagging skin on the face and neck is most often noted after medication-driven weight loss, with facial changes typically...

Adtran launches optical cesium clock upgrade to enhance short-term stability for precision timing applications

News summary: Industries such as metrology, aerospace and defense need ultra-stable timing for accurate data collection and reliable communication Adtran’s Oscilloquartz optical cesium clock now...

Logitech Announces Fourth Consecutive Quarter of Sales Growth

Gaming Sales Near Pandemic-High Levels; Company Raises FY 2025 Outlook LAUSANNE, Switzerland & SAN JOSE, Calif.–(BUSINESS WIRE)– SIX Swiss Exchange Ad hoc announcement pursuant to...

Rimini Street to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025

LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, the leading third-party support provider for...

Liberty Global and Juniper Networks Collaborate to Demonstrate Seamless Cloud Connections

Technology explores simplifying and securing hybrid multicloud connectivity at scale to deliver superior user experiences for enterprise and consumer customers SUNNYVALE, Calif. & DENVER, Colorado–(BUSINESS...